GLP-1 activation is a powerful tool for weight management, blood sugar regulation, and metabolic health
Some in vitro data suggest modest CYP3A4 induction by glucocorticoids, but clinical studies have not demonstrated a significant reduction in losartan's active metabolite concentrations during co-administration [4]
The high dose compensates for potentially impaired absorption and ensures adequate tissue stores
Therefore, even a disrupted and more permeable BBB can represent a serious challenge to brain-targeted drug delivery
Deep Dive: The GLP-1 Impact Background: Starting Tirzepatide (April 2024) In April 2024, I started Tirzepatide (Mounjaro/Zepbound) at 2.5mg, gradually escalating to 10mg over several months
Detailed Category Analysis# Mechanism of Action# Amycretin : Unimolecular dual GLP-1 and amylin receptor agonist